| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | -12.8% |
| Cost of Revenue | $57.6M | -7.9% |
| Gross Profit | $1.13B | -13.0% |
| R&D Expense | $95.4M | -1.2% |
| SG&A Expense | $320.0M | -11.0% |
| Operating Income | $21.9M | +182.6% |
| Pre-tax Income | $20.1M | +171.2% |
| Income Tax | -$16.8M | -1012.0% |
| Net Income | $36.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $416.4M | +14.4% |
| Accounts Receivable | $36.7M | -28.2% |
| Current Assets | $495.1M | +1.6% |
| Total Assets | $1.83B | -1.4% |
| Current Liabilities | $231.7M | -10.4% |
| Long-term Debt | $496.8M | +0.2% |
| Stockholders' Equity | $1.06B | +2.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $50.5M | +5.7% |
| Financing Cash Flow | -$53.8M | -216.5% |
| +190.0% |
| EPS (Basic) | $0.07 | +187.5% |
| EPS (Diluted) | $0.07 | +187.5% |